Clinical Trial

Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.
Trial Details
NCT Number NCT07503496
Lead Sponsor China Medical University Hospital
Conditions Breast Cancer Stages I, Breast Cancer Stages II, Breast Cancer Stage III
Enrollment 96 participants
Start Date 2025-04-07
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-31